Detalhe da pesquisa
1.
Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care.
Nephrol Dial Transplant
; 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253386
2.
Current trends in diabetes mellitus database research in Japan.
Diabetes Obes Metab
; 23 Suppl 2: 3-18, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33835639
3.
The Novel Mechanisms Concerning the Inhibitions of Palmitate-Induced Proinflammatory Factor Releases and Endogenous Cellular Stress with Astaxanthin on MIN6 ß-Cells.
Mar Drugs
; 15(6)2017 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632169
4.
Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study.
Front Physiol
; 14: 1156289, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37123269
5.
Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome.
Front Endocrinol (Lausanne)
; 14: 1111984, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36793276
6.
Correction: Kohsaka et al. Risk-Benefit Balance of Renin-Angiotensin-Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia. J. Clin. Med. 2022, 11, 5828.
J Clin Med
; 12(7)2023 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37048834
7.
Association of Hyperkalemia and Hypokalemia with Patient Characteristics and Clinical Outcomes in Japanese Hemodialysis (HD) Patients.
J Clin Med
; 12(6)2023 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36983118
8.
Risk-Benefit Balance of Renin-Angiotensin-Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia.
J Clin Med
; 11(19)2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233692
9.
Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database.
Diabetes Ther
; 13(2): 275-286, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35006534
10.
Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment.
J Clin Endocrinol Metab
; 107(9): 2424-2432, 2022 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857060
11.
Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER.
Diabetes Ther
; 13(2): 251-264, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34962628
12.
Serum lactate levels are associated with serum alanine aminotransferase and total bilirubin levels in patients with type 2 diabetes mellitus: A cross-sectional study.
Diabetes Res Clin Pract
; 149: 1-8, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30711436
13.
Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK.
J Diabetes Res
; 2018: 9256482, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713651
14.
Abnormal glucose tolerance in a patient with pheochromocytoma and ACTH-independent subclinical Cushing's syndrome involving the same adrenal gland.
J Int Med Res
; 47(7): 3360-3370, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31256733